Food & Health
Germany’s Merck KGaA agreed Monday to acquire Nasdaq-listed RNA-interference biotech Silence Therapeutics (SLN) for $1.3 billion, offering a premium of more than 100% to the target’s last closing price in a deal that reshapes the acquirer’s long-horizon therapeutic pipeline.
For investors...
AstraZeneca (AZN) deepened its artificial-intelligence push on Thursday, agreeing to pay up to $1.5 billion...
GSK (GSK.L) will pour more than $800 million into a new biopharmaceutical manufacturing and R&D hub...
The FDA approved AbbVie’s (ABBV.N) tavapadon as a once-daily Parkinson’s pill on Friday,...
Eli Lilly (LLY.N) signed a research and licensing pact with Beijing-based InnoCare Pharma (688428.SS)...
Roche (ROG.S) said its experimental drug enicepatide meaningfully cut blood-sugar levels and body weight...
Pfizer (PFE) is pursuing roughly $2 billion from Poland and Romania over cancelled Covid-19 vaccine contracts,...
Trending
CATEGORIES
Categories
SIGNUP TO OUR NEWSLETTER
Subscribe
Get breaking market insights directly to your inbox